ENXTPA:RNO
ENXTPA:RNOAuto

Renault Valuation After 23.5% Slide in 2025 and EV Strategy Shifts

If you have been wondering whether Renault at €36.01 is a bargain or a value trap, you are not alone, and this breakdown is designed to give you a clear, valuation focused answer. The stock has climbed 3.5% over the last week and 4.0% over the past month, but it is still down 23.5% year to date and 14.3% over the last year, which hints that sentiment and risk perception may still be in flux despite a 17.0% gain over three years and 7.8% over five years. Recent headlines around Renault have...
ENXTPA:ALNTG
ENXTPA:ALNTGSoftware

3 European Penny Stocks With Market Caps Under €60M To Consider

As the European markets experience mixed returns, with some indices showing modest gains amid hopes for interest rate cuts, investors are increasingly exploring diverse opportunities. Penny stocks, often associated with smaller or newer companies, remain a relevant and intriguing area for those seeking growth potential at lower price points. By focusing on firms with strong financials and clear growth prospects, investors can uncover promising opportunities in this often overlooked segment of...
ENXTPA:MC
ENXTPA:MCLuxury

What LVMH Moët Hennessy Louis Vuitton Société Européenne (ENXTPA:MC)'s Dividend And Emissions Cut Progress Means For Shareholders

LVMH Moët Hennessy Louis Vuitton paid an interim dividend of €5.50 per share on December 4, 2025, following an ex-dividend date of December 2 and a final trading day with dividend rights on December 1. The group also marked strong progress on its Life 360 sustainability roadmap, celebrating awards for initiatives that helped cut Scopes 1 and 2 greenhouse gas emissions by 55% since 2019, embedding environmental goals more deeply into governance and capital allocation. We’ll now examine how...
ENXTPA:EXENS
ENXTPA:EXENSAerospace & Defense

Is Exosens (ENXTPA:EXENS) Locking In Theon To Cement Its Defense Moat Through 2030?

Exosens and Theon International recently extended their long-term commercial agreement for image intensifier tubes by three years to 2030, converting 2027–2028 options into firm orders and lifting annual supply volumes to address persistent global shortages. This extension, which allows Theon to procure over 400,000 tubes in five years, deepens Exosens’ role as a preferred defense supplier and supports ongoing capacity investments and technology upgrades in a structurally constrained...
ENXTPA:FCMC
ENXTPA:FCMCHospitality

European Undiscovered Gems To Explore In December 2025

As European markets navigate a landscape of mixed returns, with the pan-European STOXX Europe 600 Index inching higher on optimism around potential interest rate cuts, investors are keenly observing economic indicators such as inflation and GDP revisions that hint at underlying strengths and challenges. In this dynamic environment, identifying stocks that exhibit resilience through robust fundamentals and growth potential becomes crucial for those seeking opportunities amidst evolving market...
ENXTPA:SU
ENXTPA:SUElectrical

Does Schneider’s Marks & Spencer Decarbonization Partnership Reshape The Bull Case For Schneider Electric (ENXTPA:SU)?

Marks & Spencer recently announced the launch of its RE:Spark supply chain decarbonization program, developed with Schneider Electric and powered by the Zeigo Hub digital platform to help global suppliers measure emissions and adopt renewable electricity solutions such as onsite solar and power purchase agreements. This collaboration underscores Schneider Electric’s role at the center of corporate decarbonization efforts while its exposure to expanding smart home and control room technology...
ENXTPA:MEDCL
ENXTPA:MEDCLPharmaceuticals

MedinCell (ENXTPA:MEDCL): Assessing Valuation After Teva’s FDA Filing for Olanzapine Long-Acting Injectable

MedinCell (ENXTPA:MEDCL) has been in focus after partner Teva filed a New Drug Application with the U.S. FDA for its olanzapine long acting injectable, which is built on MedinCell’s BEPO technology. See our latest analysis for MedinCell. The latest regulatory milestone appears to have reignited interest in MedinCell, with the 1 day share price return of 3.85 percent and a 90 day share price return of 41.39 percent contributing to a robust 1 year total shareholder return of 77.19 percent. This...
ENXTPA:ARG
ENXTPA:ARGIndustrial REITs

Energy‑Efficient Logistics Expansion Might Change The Case For Investing In Argan (ENXTPA:ARG)

In recent months, ARGAN announced a new lease with JUNG LOGISTIQUE for a 30,000 sq.m AutOnom® logistics facility in Tournan-en-Brie and confirmed with DECATHLON the modernization of heating systems across more than 170,000 sq.m of logistics space using next-generation heat pumps. These projects underline ARGAN’s focus on pairing logistics expansion with concrete energy-efficiency upgrades, enhancing the resilience and decarbonization profile of its tenant portfolio. We’ll now examine how...
ENXTPA:TTE
ENXTPA:TTEOil and Gas

Is TotalEnergies (ENXTPA:TTE) Still Undervalued After Its Recent Share Price Strength?

TotalEnergies (ENXTPA:TTE) has been grinding higher over the past month, outpacing many European energy peers as investors reassess its mix of traditional oil assets and growing renewables exposure, with the stock still trading at a moderate valuation. See our latest analysis for TotalEnergies. At around $55.82, the recent pullback after a steady 30 day share price return of 3.29% sits against a solid 10.89% 1 year total shareholder return, suggesting momentum is cooling slightly rather than...
ENXTPA:EL
ENXTPA:ELMedical Equipment

Is EssilorLuxottica (ENXTPA:EL) Quietly Recasting Its Moat Through Science-Led, AI-Driven Eyewear Innovation?

EssilorLuxottica recently created a high-profile Scientific Advisory Committee of globally recognized experts in physics, ophthalmology, audiology, mathematics and bioethics to guide its research in areas such as oculomics, AI and optics. This move signals a deeper push to fuse advanced science with wearable technology, potentially sharpening the company’s edge in AI-powered eyewear and broader health-focused innovation. We’ll now examine how EssilorLuxottica’s new Scientific Advisory...
ENXTPA:MLHK
ENXTPA:MLHKAerospace & Defense

Did H&K's Stronger Nine-Month Earnings Just Shift H&K's (ENXTPA:MLHK) Investment Narrative?

H&K AG reported past earnings results for the nine months ended September 30, 2025, with sales rising to €279.1 million from €253.6 million and net income increasing to €24 million from €17 million, lifting basic earnings per share from continuing operations to €0.68 from €0.48 a year earlier. This improvement in profitability suggests that H&K AG converted higher revenues into stronger earnings, which can influence how investors view its operational efficiency. We will now examine how H&K...
ENXTPA:ATO
ENXTPA:ATOIT

Is Atos (ENXTPA:ATO) Using Sports-Tech Partnerships To Quietly Rewrite Its Digital Strategy?

Earlier this month, CONMEBOL announced Atos as its first Official Innovation Partner for major South American club competitions, tasking the company with building new digital platforms to deepen fan engagement, while Atos also unveiled a joint research program to strengthen AI security and expanded its sports-technology push in Saudi Arabia. Together, these moves highlight how Atos is leaning on sports technology and secure AI capabilities to reposition its business mix toward higher-value...
ENXTPA:ERF
ENXTPA:ERFLife Sciences

Is Eurofins Scientific Fairly Priced After Portfolio Streamlining and 2025 Share Price Rebound?

If you have been wondering whether Eurofins Scientific is still a quality stock at a fair price, you are not alone, as many investors are trying to figure out if the current share price matches its long term potential. Despite a choppy few weeks, with the share price down 4.4% over the last 7 days and 2.6% over the last month, Eurofins is still up 16.3% year to date and 20.2% over the past year. This hints that the market may be warming back up to its story after a tougher 3 and 5 year...